HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fluorouracil 5% and 0.5% creams for the treatment of actinic keratosis: equivalent efficacy with a lower concentration and more convenient dosing schedule.

Abstract
Several formulations and concentrations of topical fluorouracil have received US Food and Drug Administration (FDA) approval for the treatment of actinic keratosis (AK). The most commonly used are the fluorouracil 5% and 0.5% creams. In clinical trials, these formulations have demonstrated a marked ability to partially and completely eradicate AK lesions. Application site irritation, erythema, and burning are common side effects of both formulations, but comparative data suggest that the fluorouracil 0.5% cream is more cost-effective and may be safer, more tolerable, and as efficacious as fluorouracil 5% cream.
AuthorsJoseph L Jorizzo, Patrick S Carney, William T Ko, Perry Robins, Susan H Weinkle, Wm Philip Werschler
JournalCutis (Cutis) Vol. 74 Issue 6 Suppl Pg. 18-23 (Dec 2004) ISSN: 0011-4162 [Print] United States
PMID15666898 (Publication Type: Comparative Study, Journal Article, Review)
Chemical References
  • Antimetabolites, Antineoplastic
  • Emulsions
  • Fluorouracil
Topics
  • Administration, Cutaneous
  • Antimetabolites, Antineoplastic (administration & dosage, economics, pharmacokinetics)
  • Drug Administration Schedule
  • Emulsions
  • Fluorouracil (administration & dosage, economics, pharmacokinetics)
  • Humans
  • Keratosis (drug therapy)
  • Photosensitivity Disorders (drug therapy)
  • Therapeutic Equivalency

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: